FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160501234> ?p ?o ?g. }

• W2160501234 endingPage "574" @default.
• W2160501234 startingPage "570" @default.
• W2160501234 abstract "Patients with locally advanced (ie clinically extravesical) transitional cell carcinoma are at high risk for recurrence after cystectomy. Although randomized trials have established an incremental benefit from the addition of chemotherapy in this setting, many patients still have disease relapse, and therefore it is necessary to determine patient and tumor characteristics that correlate with outcome in this setting. We investigated the tumor expression of several metastasis related genes and the association of gene expression with disease specific survival of patients with locally advanced transitional cell carcinoma treated randomized to either neoadjuvant or adjuvant chemotherapy and radical cystectomy.Archival paraffin embedded specimens were available for 64 patients enrolled in a clinical trial of the methotrexate, vinblastine, doxorubicin and cisplatin regimen and cystectomy. Only samples obtained before exposure to chemotherapy were studied. The expression of several metastasis related genes, including basic fibroblast growth factor, vascular endothelial growth factor (VEGF), interleukin-8, matrix metalloproteinase (MMP)-9, and E-cadherin were assayed on paraffin sections using a colorimetric in situ hybridization assay.Expression of basic fibroblast growth factor, interleukin-8 and MMP-9 did not correlate with outcome. Expression of VEGF and E-cadherin were strongly related to disease specific survival. In addition, the ratio of MMP-9-to-E-cadherin was strongly prognostic for disease specific survival.These data advance the hypotheses that VEGF expression and an invasive phenotype characterized by the ratio of MMP-9-to-E-cadherin expression are mechanistically relevant to clinically aggressive locally advanced bladder cancers that are not cured by currently available combined modality treatment. Thus, in our view there is a compelling rationale to target these aspects of the malignant phenotype in this patient population." @default.
• W2160501234 created "2016-06-24" @default.
• W2160501234 creator A5002737792 @default.
• W2160501234 creator A5014176442 @default.
• W2160501234 creator A5025147400 @default.
• W2160501234 creator A5027897588 @default.
• W2160501234 creator A5029797576 @default.
• W2160501234 creator A5051405334 @default.
• W2160501234 creator A5058588554 @default.
• W2160501234 creator A5064464692 @default.
• W2160501234 creator A5069116689 @default.
• W2160501234 date "2004-02-01" @default.
• W2160501234 modified "2023-09-30" @default.
• W2160501234 title "Correlation of Metastasis Related Gene Expression and Relapse-Free Survival in Patients With Locally Advanced Bladder Cancer Treated With Cystectomy and Chemotherapy" @default.
• W2160501234 cites W1426844501 @default.
• W2160501234 cites W1439606022 @default.
• W2160501234 cites W1975918912 @default.
• W2160501234 cites W1984557785 @default.
• W2160501234 cites W2033511033 @default.
• W2160501234 cites W2061385217 @default.
• W2160501234 cites W2078093069 @default.
• W2160501234 cites W2095512424 @default.
• W2160501234 cites W2097783657 @default.
• W2160501234 cites W2113156769 @default.
• W2160501234 cites W2470654889 @default.
• W2160501234 cites W2619733974 @default.
• W2160501234 cites W4376546343 @default.
• W2160501234 doi "https://doi.org/10.1097/01.ju.0000108845.91485.20" @default.
• W2160501234 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14713761" @default.
• W2160501234 hasPublicationYear "2004" @default.
• W2160501234 type Work @default.
• W2160501234 sameAs 2160501234 @default.
• W2160501234 citedByCount "71" @default.
• W2160501234 countsByYear W21605012342012 @default.
• W2160501234 countsByYear W21605012342013 @default.
• W2160501234 countsByYear W21605012342014 @default.
• W2160501234 countsByYear W21605012342015 @default.
• W2160501234 countsByYear W21605012342016 @default.
• W2160501234 countsByYear W21605012342017 @default.
• W2160501234 countsByYear W21605012342018 @default.
• W2160501234 countsByYear W21605012342019 @default.
• W2160501234 countsByYear W21605012342021 @default.
• W2160501234 countsByYear W21605012342022 @default.
• W2160501234 countsByYear W21605012342023 @default.
• W2160501234 crossrefType "journal-article" @default.
• W2160501234 hasAuthorship W2160501234A5002737792 @default.
• W2160501234 hasAuthorship W2160501234A5014176442 @default.
• W2160501234 hasAuthorship W2160501234A5025147400 @default.
• W2160501234 hasAuthorship W2160501234A5027897588 @default.
• W2160501234 hasAuthorship W2160501234A5029797576 @default.
• W2160501234 hasAuthorship W2160501234A5051405334 @default.
• W2160501234 hasAuthorship W2160501234A5058588554 @default.
• W2160501234 hasAuthorship W2160501234A5064464692 @default.
• W2160501234 hasAuthorship W2160501234A5069116689 @default.
• W2160501234 hasConcept C121608353 @default.
• W2160501234 hasConcept C126322002 @default.
• W2160501234 hasConcept C142724271 @default.
• W2160501234 hasConcept C143998085 @default.
• W2160501234 hasConcept C167734588 @default.
• W2160501234 hasConcept C2775910329 @default.
• W2160501234 hasConcept C2776694085 @default.
• W2160501234 hasConcept C2777025900 @default.
• W2160501234 hasConcept C2777132456 @default.
• W2160501234 hasConcept C2778065480 @default.
• W2160501234 hasConcept C2779013556 @default.
• W2160501234 hasConcept C2780352672 @default.
• W2160501234 hasConcept C502942594 @default.
• W2160501234 hasConcept C71924100 @default.
• W2160501234 hasConceptScore W2160501234C121608353 @default.
• W2160501234 hasConceptScore W2160501234C126322002 @default.
• W2160501234 hasConceptScore W2160501234C142724271 @default.
• W2160501234 hasConceptScore W2160501234C143998085 @default.
• W2160501234 hasConceptScore W2160501234C167734588 @default.
• W2160501234 hasConceptScore W2160501234C2775910329 @default.
• W2160501234 hasConceptScore W2160501234C2776694085 @default.
• W2160501234 hasConceptScore W2160501234C2777025900 @default.
• W2160501234 hasConceptScore W2160501234C2777132456 @default.
• W2160501234 hasConceptScore W2160501234C2778065480 @default.
• W2160501234 hasConceptScore W2160501234C2779013556 @default.
• W2160501234 hasConceptScore W2160501234C2780352672 @default.
• W2160501234 hasConceptScore W2160501234C502942594 @default.
• W2160501234 hasConceptScore W2160501234C71924100 @default.
• W2160501234 hasIssue "2" @default.
• W2160501234 hasLocation W21605012341 @default.
• W2160501234 hasLocation W21605012342 @default.
• W2160501234 hasOpenAccess W2160501234 @default.
• W2160501234 hasPrimaryLocation W21605012341 @default.
• W2160501234 hasRelatedWork W1528504062 @default.
• W2160501234 hasRelatedWork W18081430 @default.
• W2160501234 hasRelatedWork W1978127872 @default.
• W2160501234 hasRelatedWork W1998062456 @default.
• W2160501234 hasRelatedWork W2111831003 @default.
• W2160501234 hasRelatedWork W2614838328 @default.
• W2160501234 hasRelatedWork W2946011640 @default.
• W2160501234 hasRelatedWork W3134279723 @default.
• W2160501234 hasRelatedWork W4299398734 @default.
• W2160501234 hasRelatedWork W92201526 @default.
• W2160501234 hasVolume "171" @default.

• next